Compugen Ltd
NASDAQ:CGEN
Balance Sheet
Balance Sheet Decomposition
Compugen Ltd
Current Assets | 114.6m |
Cash & Short-Term Investments | 50.7m |
Receivables | 63.5m |
Other Current Assets | 365k |
Non-Current Assets | 6.8m |
Long-Term Investments | 3m |
PP&E | 2.5m |
Other Non-Current Assets | 1.2m |
Current Liabilities | 26.3m |
Accounts Payable | 14.5m |
Accrued Liabilities | 632k |
Other Current Liabilities | 11.1m |
Non-Current Liabilities | 29.5m |
Other Non-Current Liabilities | 29.5m |
Balance Sheet
Compugen Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
26
|
3
|
10
|
26
|
6
|
9
|
7
|
8
|
11
|
14
|
|
Cash |
26
|
3
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
0
|
0
|
0
|
26
|
6
|
9
|
7
|
8
|
11
|
14
|
|
Short-Term Investments |
48
|
78
|
51
|
4
|
39
|
34
|
117
|
109
|
72
|
37
|
|
Total Receivables |
0
|
8
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
61
|
|
Accounts Receivables |
0
|
8
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
61
|
|
Other Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
2
|
2
|
2
|
1
|
2
|
3
|
6
|
3
|
3
|
|
Total Current Assets |
75
|
91
|
63
|
31
|
47
|
45
|
129
|
123
|
86
|
115
|
|
PP&E Net |
3
|
6
|
6
|
5
|
3
|
6
|
5
|
4
|
3
|
3
|
|
PP&E Gross |
3
|
6
|
6
|
5
|
3
|
6
|
5
|
4
|
3
|
3
|
|
Accumulated Depreciation |
10
|
2
|
3
|
5
|
6
|
5
|
5
|
6
|
6
|
5
|
|
Long-Term Investments |
37
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
|
Total Assets |
115
N/A
|
99
-14%
|
71
-28%
|
39
-46%
|
53
+37%
|
54
+1%
|
138
+157%
|
132
-4%
|
94
-29%
|
121
+29%
|
|
Liabilities | |||||||||||
Accounts Payable |
4
|
7
|
5
|
6
|
3
|
1
|
1
|
5
|
2
|
4
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
6
|
5
|
8
|
9
|
10
|
12
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
2
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
0
|
11
|
|
Total Current Liabilities |
7
|
7
|
5
|
6
|
10
|
7
|
11
|
17
|
12
|
26
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
2
|
3
|
3
|
3
|
6
|
9
|
8
|
8
|
5
|
30
|
|
Total Liabilities |
9
N/A
|
9
+6%
|
8
-19%
|
9
+24%
|
16
+69%
|
15
-3%
|
19
+20%
|
26
+38%
|
17
-35%
|
56
+238%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
219
|
240
|
271
|
308
|
331
|
358
|
388
|
422
|
456
|
475
|
|
Additional Paid In Capital |
324
|
329
|
334
|
337
|
368
|
396
|
507
|
529
|
533
|
540
|
|
Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
106
N/A
|
90
-15%
|
64
-29%
|
29
-54%
|
37
+27%
|
38
+3%
|
120
+213%
|
107
-11%
|
78
-27%
|
66
-16%
|
|
Total Liabilities & Equity |
115
N/A
|
99
-14%
|
71
-28%
|
39
-46%
|
53
+37%
|
54
+1%
|
138
+157%
|
132
-4%
|
94
-29%
|
121
+29%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
50
|
51
|
51
|
51
|
60
|
68
|
84
|
86
|
87
|
89
|